The "Transgender Child": How Psychiatry Created Its Most Destructive Diagnosis - Stella & Mia (#18)
19 June 2025
Global
In this episode, researcher Mia Hughes excavates the murky origins of childhood gender dysphoria as a clinical category, tracing it to 1960s American studies that may have been built on profoundly unreliable foundations. Stella O'Malley adds her own childhood testimony about wanting to be a boy. Together they ask whether the diagnosis ever made sense — and whether it is too dangerous to keep. For European countries that built clinical protocols on these same foundations and are now urgently reviewing them, this is essential listening.
Few questions cut closer to the crisis in youth gender medicine than this: did the diagnosis of childhood gender dysphoria ever rest on solid ground? In episode eighteen, Mia Hughes and Stella O'Malley look backward, examining how a clinical category came into being in the 1960s and asking whether the assumptions embedded at its origin have shaped — and distorted — everything that followed. It is a conversation that European clinicians and policymakers can no longer afford to avoid. Hughes, whose research spans the institutional history of gender medicine, reconstructs the early American studies from which the concept of the transgender child emerged. The research subjects were largely effeminate boys, and the category appears to have been constructed around them rather than discovered within them. Complicating matters further, some of the adult males passing through early gender clinics seem to have misrepresented their histories in order to gain access to hormones, feeding researchers a skewed picture of childhood gender nonconformity as a reliable predictor of adult transsexualism. The diagnosis, Hughes argues, may have been built on unreliable data from the very beginning. O'Malley's contribution is intimate and rare. As a child she desperately wanted to be a boy — an experience she describes with precision and without self-pity. That testimony matters not as anecdote but as evidence: it illustrates what gender dysphoria can feel like from the inside, and implicitly asks what would have happened to a child like her if today's clinical pathways had existed in the Ireland of her youth. For many European listeners, the answer will be uncomfortable. The episode closes in on a genuinely hard question: should childhood gender dysphoria remain a formal diagnosis in the DSM at all? Remove it and clinically distressed children lose a framework. Keep it and the diagnosis functions as a gateway — one that, in the current cultural climate, may open far too easily. Neither option is clean, and Hughes and O'Malley resist the temptation of easy resolution. For continental Europe this history carries particular weight. The Dutch Protocol — developed in Amsterdam in the 1990s and subsequently exported across the continent — was a downstream consequence of the very diagnostic assumptions Hughes interrogates here. Sweden and Finland have since restricted puberty blockers and cross-sex hormones for minors on grounds of insufficient evidence. The Netherlands is conducting its own review. Germany's new trans law has prompted sharp debate among clinicians. In each of these countries the foundational question is the same one Hughes asks: what exactly did we think we knew, and how did we come to think we knew it? European health agencies and professional bodies currently revising their guidelines will find both a historical resource and a challenge in this episode. If the diagnosis was flawed at its origin, then decades of clinical practice built on it require not just revision but genuine reckoning — an uncomfortable position for institutions that authorised those practices, but an essential one.
